Personalized Medicine: Consumer Concerns About Coverage, Affordability and Privacy
Health Populi
MAY 30, 2018
This is important because in 2017, one in four new drugs approved by the FDA were designed to treat a small population, falling. The team analyzed data-sharing guidelines across 230 policy documents published between 1996 and 2017. into the precision medicine category. Note that autonomy and privacy rank with the most mentions.
174 
Let's personalize your content